| NDSN | 8-K | neutral | 4/10 | Nordson completed the acquisition of Contrinex Holding SA for approximately $168 million in enterprise value, adding a S | Oct 23, 2026 |
| MBOT | 8-K | neutral | 2/10 | Microbot Medical filed an 8-K announcing its attendance at the SIR EDGE 2026 conference (Oct 25-27) and the concurrent A | Oct 23, 2026 |
| LSBK | 8-K | neutral | 2/10 | Lake Shore Bancorp declared a quarterly cash dividend of $0.09 per share, payable November 11, 2026 to shareholders of r | Oct 23, 2026 |
| GEG | 8-K | neutral | 3/10 | Director Eric Scheyer notified Great Elm Group's board on October 21, 2026 that he will not stand for re-election at the | Oct 23, 2026 |
| BR | 8-K | neutral | 1/10 | Broadridge Financial Solutions filed an 8-K reporting a routine headquarters relocation to 605 Third Avenue, New York, N | Oct 23, 2026 |
| FISV | 8-K | neutral | 2/10 | Fiserv appointed Raj Seshadri, a former Mastercard executive, to its board effective November 30, 2026, and disclosed th | Oct 23, 2026 |
| LKQ | 8-K | bearish | 8/10 | LKQ reported preliminary Q3 2026 results well below expectations, with revenue of $3.32B (down 5.1% YoY), a GAAP net los | Oct 23, 2026 |
| AMR | 8-K | neutral | 4/10 | Alpha Metallurgical Resources reported preliminary Q3 2026 results with a net loss of $9.3M (-$0.73/diluted share) and A | Oct 23, 2026 |
| FHB | 8-K | bearish | 6/10 | First Hawaiian reported Q3 2026 GAAP diluted EPS of $0.52, missing the $0.59 consensus by 11.9%, with net income of $63. | Oct 23, 2026 |
| NJR | 8-K | neutral | 3/10 | New Jersey Resources Corp's wholly-owned subsidiary, New Jersey Natural Gas Company, issued and sold $50 million of 5.43 | Oct 23, 2026 |
| ORIC | 8-K | bullish | 7/10 | ORIC Pharmaceuticals presented updated Phase 1b data for enozertinib in 1L EGFR atypical NSCLC at ESMO 2026, showing an | Oct 23, 2026 |
| SXTP | 8-K | neutral | 4/10 | 60 Degrees Pharmaceuticals filed an 8-K furnishing an updated investor presentation (October 23, 2026) detailing progres | Oct 23, 2026 |
| GNTX | 8-K | bearish | 7/10 | Gentex reported Q3 2026 GAAP EPS of $0.43 on revenue of $647.7M, missing consensus estimates of $0.50 EPS and $669.6M re | Oct 23, 2026 |
| NEUP | 8-K | neutral | 2/10 | Neuphoria Therapeutics extended the expiration date of its shareholder rights plan (poison pill) by one year, from Octob | Oct 23, 2026 |
| RBCAA | 8-K | neutral | 5/10 | Republic Bancorp reported Q3 2026 net income of $31.1M and diluted EPS of $1.59, up 5% YoY from $1.52, driven by Core Ba | Oct 23, 2026 |
| WRLD | 8-K | bullish | 6/10 | World Acceptance Corporation reported Q2 FY2027 GAAP net income of $8.8M ($1.92/diluted share), a sharp turnaround from | Oct 23, 2026 |
| IPM | 8-K | neutral | 5/10 | IPM signed a definitive agreement to acquire AdTech's managed IT services business for up to $2.7 million in a two-stage | Oct 23, 2026 |
| RITM | 8-K | bullish | 6/10 | Rithm Capital Corp. reported Q3 2026 GAAP net income of $217.1M ($0.38/diluted share) and Earnings Available for Distrib | Oct 23, 2026 |
| BCPC | 8-K | bullish | 6/10 | Balchem reported another strong quarter with record net sales, net earnings, and adjusted EBITDA, driven by growth acros | Oct 23, 2026 |
| SLB | 8-K | mixed | 5/10 | SLB reported Q3 2026 revenue of $9.45B (+6% YoY, +5% sequentially) and GAAP EPS of $0.49 (-2% YoY, -6% sequentially), bu | Oct 23, 2026 |
| JAKK | 8-K | bullish | 6/10 | JAKKS Pacific reported Q3 2026 net sales of $254.2M (+20% YoY) and GAAP diluted EPS of $2.48, significantly beating cons | Oct 23, 2026 |
| AXP | 8-K | bullish | 7/10 | American Express reported Q3 2026 adjusted EPS of $4.68, a 4.0% beat vs consensus of $4.50, on record revenue of $20.1B | Oct 23, 2026 |
| BAH | 8-K | bullish | 7/10 | Booz Allen Hamilton reported Q2 FY27 results with Adjusted Diluted EPS of $1.76, an 18.1% YoY increase and a 19.0% beat | Oct 23, 2026 |
| EAF | 8-K | bearish | 6/10 | GrafTech Q3 2026 net sales fell 3% YoY to $140M, net loss widened to $47M ($1.76/share) from $28M a year ago, including | Oct 23, 2026 |
| TNGX | 8-K | bullish | 7/10 | Tango Therapeutics reported highly promising Phase 1/2 data for vopimetostat + daraxonrasib in MTAP-deleted PDAC, showin | Oct 23, 2026 |
| FCNCA | 8-K | bullish | 6/10 | First Citizens BancShares reported Q3 2026 adjusted EPS of $55.37, a 20.4% beat vs the $45.98 consensus, driven by stron | Oct 23, 2026 |
| FIP | 8-K | mixed | 6/10 | FTAI Infrastructure's Jefferson Terminal subsidiary announced a $270 million private note offering to fund the $255 mill | Oct 23, 2026 |
| MKTX | 8-K | neutral | 4/10 | MarketAxess reported Q3 2026 GAAP EPS of $1.53, down 17% YoY, and revenue of $210.4 million, up 1% YoY. The miss was dri | Oct 23, 2026 |
| ALV | 8-K | bearish | 6/10 | Autoliv reported Q3 2026 results with net sales of $2,693 million (-0.5% YoY), GAAP diluted EPS of $2.13 (-6.8% YoY), an | Oct 23, 2026 |
| ZYME | 8-K | bullish | 7/10 | Zymeworks entered into an exclusive global license and collaboration agreement with Roche for ZW209, a trispecific T-cel | Oct 23, 2026 |